Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-20

Clinical Trial Update: Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating optimal blood pressure and cholesterol targets to prevent recurrent stroke in individuals with hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Istituto Auxologico Italiano | Conditions: Stroke, Transient Ischemic Attack | Phase 4 | Status: COMPLETED